ME00246B - Formulacije hfa-suspenzija koje sadrže anhidrat - Google Patents

Formulacije hfa-suspenzija koje sadrže anhidrat

Info

Publication number
ME00246B
ME00246B MEP-2008-473A MEP47308A ME00246B ME 00246 B ME00246 B ME 00246B ME P47308 A MEP47308 A ME P47308A ME 00246 B ME00246 B ME 00246B
Authority
ME
Montenegro
Prior art keywords
anhydrate
hfa
suspension formulation
formulation
suspension
Prior art date
Application number
MEP-2008-473A
Other languages
German (de)
English (en)
French (fr)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP47308A publication Critical patent/MEP47308A/xx
Publication of ME00246B publication Critical patent/ME00246B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Pronalazak se odnosi na formulaciju, sa potisnim gasom, suspenzije, kristalnog anhidrata (1α,2β,4β, 5α,7β)-7-[(hidroksidi-2-tienilacetil)oksi]-9,9-dimetil-3-oksa-9-azo-niatriciklo[3.3.1.0 2,4 ]nonan-bromida
MEP-2008-473A 2002-03-28 2003-03-20 Formulacije hfa-suspenzija koje sadrže anhidrat ME00246B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats
PCT/EP2003/002899 WO2003082244A2 (de) 2002-03-28 2003-03-20 Hfa-suspensionsformulierungen eines anhydrats

Publications (2)

Publication Number Publication Date
MEP47308A MEP47308A (en) 2011-02-10
ME00246B true ME00246B (me) 2011-05-10

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-473A ME00246B (me) 2002-03-28 2003-03-20 Formulacije hfa-suspenzija koje sadrže anhidrat

Country Status (21)

Country Link
EP (1) EP1492498A2 (me)
JP (1) JP5147158B2 (me)
KR (1) KR101005717B1 (me)
CN (1) CN1642525A (me)
AU (1) AU2003221509B2 (me)
BR (1) BR0308709A (me)
CA (1) CA2479638C (me)
DE (1) DE10214264A1 (me)
EA (1) EA008610B1 (me)
EC (1) ECSP045322A (me)
HR (1) HRP20040890A2 (me)
IL (1) IL163696A0 (me)
ME (1) ME00246B (me)
MX (1) MXPA04009338A (me)
NO (1) NO20044004L (me)
NZ (1) NZ536030A (me)
PL (1) PL371295A1 (me)
RS (1) RS52481B (me)
UA (1) UA79776C2 (me)
WO (1) WO2003082244A2 (me)
ZA (1) ZA200405637B (me)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007144531A (ru) * 2005-05-02 2009-06-10 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Новые кристаллические формы тиотропийбромида
AU2006243238B2 (en) * 2005-05-02 2012-05-24 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PL3111926T3 (pl) * 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
JP6781831B2 (ja) * 2016-09-19 2020-11-04 メキシケム フロー エセ・ア・デ・セ・ヴェ 医薬組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP1102579B1 (de) * 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
DE50115277D1 (de) * 2000-10-31 2010-02-04 Boehringer Ingelheim Pharma Arzneimittelkompositionen aus tiotropiumsalzen und
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
BR0308709A (pt) 2005-01-04
JP2005527550A (ja) 2005-09-15
UA79776C2 (en) 2007-07-25
JP5147158B2 (ja) 2013-02-20
HRP20040890A2 (en) 2005-06-30
RS52481B (en) 2013-02-28
MXPA04009338A (es) 2005-01-25
NZ536030A (en) 2006-07-28
AU2003221509A1 (en) 2003-10-13
EP1492498A2 (de) 2005-01-05
DE10214264A1 (de) 2003-10-16
CN1642525A (zh) 2005-07-20
AU2003221509B2 (en) 2008-01-24
ZA200405637B (en) 2005-07-27
KR101005717B1 (ko) 2011-01-05
WO2003082244A2 (de) 2003-10-09
IL163696A0 (en) 2005-12-18
CA2479638C (en) 2011-01-04
PL371295A1 (en) 2005-06-13
MEP47308A (en) 2011-02-10
ECSP045322A (es) 2005-01-28
EA200401159A1 (ru) 2005-04-28
EA008610B1 (ru) 2007-06-29
CA2479638A1 (en) 2003-10-09
WO2003082244A3 (de) 2004-02-05
KR20040098022A (ko) 2004-11-18
YU86004A (sh) 2006-08-17
NO20044004L (no) 2004-10-05

Similar Documents

Publication Publication Date Title
EA200401142A1 (ru) Микронизированный кристаллический тиотропийбромид
YU50903A (sh) Postupak za pripremanje antiholinergikuma,tiotropijumbromida
MEP62008A (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
ME00243B (me) Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje lijeka
CY1105543T1 (el) Σκευασματα εναιωρηματων με hfa που περιεχουν αντιχολινεργικο
DK1087960T3 (da) Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
ECSP055807A (es) Quinolinilpirrolopirazoles
ES2162614T1 (es) Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas.
RS51436B (en) DERIVATIVES TRIAZOLIL TROPANA KAO MODULATORS CCR5
ME00246B (me) Formulacije hfa-suspenzija koje sadrže anhidrat
AR086573A2 (es) Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica
WO2003082855A1 (fr) Agent anti-inflammatoire
WO1994019343A3 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
WO2005062913A3 (en) Triplide 5,6-derivatives as immunomodulators and anticancer agents
EP1757285A4 (en) PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CHRONIC SINUSITIS
AU2002328824A1 (en) Isoflavone concentrate and method for production thereof
ECSP034921A (es) Anticolinérgico cristalino, metodo para su producción, y uso del mismo en la producción de una droga